Vontier Reports Third Quarter Results and Revises Full-Year 2022 Outlook
Go back to Vontier Reports Third Quarter Results and Revises Full-Year 2022 Outlook| Savient Pharmaceuticals, Inc. (NYSE: VNT) | Delayed: 31.86 -0.71 (2.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.57 | 52 Week High | $9.92 | |||
| Open | $32.35 | 52 Week Low | $9.10 | |||
| Day High | $32.57 | P/E | N/A | |||
| Day Low | $31.76 | EPS | $-0.94 | |||
| Volume | 1,049,922 | |||||
